We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-17.83%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$404B
AUM Growth
-$174B
Cap. Flow
-$8.47B
Cap. Flow %
-2.09%
Top 10 Hldgs %
31.86%
Holding
14,668
New
1,801
Increased
4,898
Reduced
5,771
Closed
1,897

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$824M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$459M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$301M
4
WBD icon
Warner Bros
WBD
+$287M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.22%
2 Technology 1.79%
3 Consumer Discretionary 1.52%
4 Communication Services 1.04%
5 Financials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNAC icon
10726
Cartesian Therapeutics
RNAC
$290M
$179K ﹤0.01%
4,554
+3,305
+265% +$98K
DSEY
10727
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$179K ﹤0.01%
+27,181
New +$229K
PRVB
10728
PUT
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$179K ﹤0.01%
44,800
-30,900
-41% -$146K
MERC icon
10729
Mercer International
MERC
$25.9M
$178K ﹤0.01%
+13,567
New +$201K
MFA
10730
MFA Financial
MFA
$893M
$178K ﹤0.01%
16,602
-211,713
-93% -$2.85M
OCUL icon
10731
PUT
Ocular Therapeutix
OCUL
$2.28B
$178K ﹤0.01%
44,300
-123,100
-74% -$465K
PMCB icon
10732
PharmaCyte Biotech
PMCB
$5.53M
$178K ﹤0.01%
78,609
+50,547
+180% +$110K
XHR
10733
Xenia Hotels & Resorts
XHR
$1.8B
$178K ﹤0.01%
12,238
-2,081
-15% -$37.1K
TRHC
10734
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$178K ﹤0.01%
69,178
+12,397
+22% +$46.5K
IS
10735
DELISTED
ironSource Ltd.
IS
$178K ﹤0.01%
74,752
+14,436
+24% +$48.3K
ALEC icon
10736
Alector
ALEC
$261M
$177K ﹤0.01%
17,379
-50,239
-74% -$501K
ASA
10737
ASA Gold and Precious Metals
ASA
$1.19B
$177K ﹤0.01%
+12,043
New +$232K
DMRC icon
10738
Digimarc Corp
DMRC
$135M
$177K ﹤0.01%
12,552
-7,620
-38% -$157K
NVVE
10739
DELISTED
Nuvve Holding Corp
NVVE
0
OGCP
10740
Empire State Realty Series 60
OGCP
$1.32B
$177K ﹤0.01%
26,629
-3,913
-13% -$31.2K
WNC icon
10741
CALL
Wabash National
WNC
$543M
$177K ﹤0.01%
13,000
-6,300
-33% -$90.9K
TRHC
10742
CALL
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$177K ﹤0.01%
69,000
+31,500
+84% +$118K
ACRS icon
10743
CALL
Aclaris Therapeutics
ACRS
$885M
$176K ﹤0.01%
+12,600
New +$177K
ETV
10744
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.81B
$176K ﹤0.01%
+13,017
New +$186K
LMNR icon
10745
PUT
Limoneira
LMNR
$250M
$176K ﹤0.01%
+12,500
New +$157K
LXP icon
10746
CALL
LXP Industrial Trust
LXP
$3.58B
$176K ﹤0.01%
3,280
-3,500
-52% -$210K
NAK
10747
PUT
Northern Dynasty Minerals
NAK
$944M
$176K ﹤0.01%
676,100
-138,400
-17% -$45.3K
PSQ icon
10748
PUT
ProShares Short QQQ
PSQ
$598M
$176K ﹤0.01%
2,440
-3,940
-62% -$263K
QRHC icon
10749
CALL
Quest Resource Holding
QRHC
$30M
$176K ﹤0.01%
43,100
+5,200
+14% +$26K
CNCE
10750
PUT
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$176K ﹤0.01%
41,700
+26,500
+174% +$105K

Similar funds

Jeff Yass's Q2 2022 Portfolio in Review

As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
  • Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
  • Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
  • Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
  • Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
  • Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
  • Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.